Long COVID

long-covid_brain-fog_feature-image.jpg

The identification of a metabolic pathway could lead to answers and new treatments for those experiencing brain fog because of long COVID. 

A young woman asleep sitting upright in a chair

We know from other viruses that viral fragments can remain in different tissues for months or even years. This could be the case for long COVID.

A woman in a dark room with her hand on her cheek, her face lit by a screen

Mainstream medicine hasn’t yet found enough evidence-based treatments for long COVID. No wonder sufferers are turning to unproven therapies.

Young man with face mask looking forlorn

Research into the social dimensions of long Covid offers invaluable insights for its prevention, treatment and care.

Men in hard hats with heads down, looking discouraged

What do disadvantaged communities need to weather long COVID? Ask them.

Professor Gail Matthews from the Kirby Institute talks about long covid

It’s estimated one in 10 people infected with SARS-CoV-2 will have lingering symptoms, but most people will improve over time.  

woman lying down on sofa, looking tired

A team from UNSW's Kirby Institute and St Vincent’s Hospital Sydney have uncovered an immune profile for long COVID, potentially paving the way for tailored treatment for those with ongoing symptoms.

a woman lies on a lounge looking lethargic

Sufferers collected evidence of their persistent symptoms, and advocated for themselves and for further research. Even the term ‘long COVID’ stems from this activism.

Man wearing face mask showing bandaid on arm where he just received COVID vaccination

One study suggests getting vaccinated halves the risk of developing long COVID.

Man with long COVID

A UNSW psychology researcher is behind neurocognitive testing recommendations that will help assess long COVID patients.

Pages